Business
Enveda Raises $311M to Push Nature-Derived AI Drugs Into Trials
Enveda raised $311M, a round that values the AI biotech at $2 billion.
Every Axis Signal story on this subject - 1 report, filed under Business
Enveda raised $311M, a round that values the AI biotech at $2 billion.